UAB researchers are probing the secrets of subretinal drusenoid deposits, which may be a leading factor in the onset of age-related macular degeneration.
Donation from Dai-ichi Life Insurance Company and Protective Life Corporation will aid new disease-changing therapies in the ADDA pipeline.
Renowned UAB HPV expert Warner Huh says new nine-valent HPV vaccine has the potential to eradicate the majority of cervical cancer.
Published in Focus on Patient Care
UAB Hospital is first in the United States to implant new Evaheart device as part of the US Pivotal Trial to test L-VAD for patients with severe congestive heart failure.
Published in Focus on Patient Care
In the Diamond Microfab Lab, gem-quality diamonds are transformed into electronics that can handle everything from ocean deeps to outer space. Watch how the patented process unfolds in The Mix.
UAB’s research links changes in genetic regions in infants with an increased risk of premature birth — and the data change the preterm paradigm.
An interdisciplinary UAB research team hopes to learn more about how emotions might keep people from getting enough exercise. 
Research to Prevent Blindness has given UAB’s Department of Ophthalmology a grant to further research of retinal and optic nerve diseases
BCRFA continues to provide substantial gifts to UAB Cancer Center to accelerate breast cancer research.
Together with European partners, UAB unravels basis of Singleton-Merten Syndrome, which causes heart calcification and early periodontitis.
UAB researchers receive a $1.25 million grant to identify and disseminate best management practices in nursing homes with a high census of Medicaid residents.
UAB neurology researcher Kristen Triebel gets substantial American Cancer Society grant to investigate the ability of patients to understand, choose and consent to treatment.
Published in Focus on Patient Care
Classic psychedelic drugs include LSD, psilocybin and mescaline. This new School of Public Health research is published in the Journal of Psychopharmacology.
During the past few years, technological innovations have opened up an entirely new way to approach scientific questions. Data-driven research starts with massive information sets — the genomic profiles of thousands of patients, for example, or millions of spam emails — and then searches for emerging patterns in that data. In the latest issue of the U.S. Chamber of Commerce’s "Business Horizon Quarterly", UAB President Ray Watts, M.D., explains the way data-driven research at UAB is being applied to find novel treatments for disease, create new products and businesses and train the next generation of innovation-savvy students.
editing the brain
Epigenetic changes are implicated in a host of neural conditions, from Alzheimer's-related memory loss to depression. Now, a revolutionary set of molecular editing tools are allowing scientists to alter the epigenome like never before. In The Mix, UAB neuroscientist Jeremy Day, Ph.D., explains how he uses these techniques in his lab, and why they could lead to an entirely new kind of therapy.
Published in Focus on Patient Care
New strategies for acquiring objective data are in their infancy, and support for better tools is needed, say experts in the International Journal of Obesity.
Roadmap of early differentiation genes points to key role for dmrt1 in how the egg incubation temperature determines the sex of a hatchling.
Neuroradiologist Robert Kessler, M.D., is using UAB’s powerful cyclotron to develop imaging tests that reveal changes caused by depression, addiction, Parkinson’s disease and more.
HPV testing alone is an effective alternative to current cervical cancer screening methods that use a Pap smear, or Pap smear-plus HPV test.
Published in Focus on Patient Care
mix scansNeurologist Hassan Fathallah-Shaykh, M.D., Ph.D., is deploying a new weapon in the war on cancer: mathematical theory. His sophisticated models of tumor growth are predicting new insights on cancer behavior — and could eventually guide treatment decisions.

News You Can Use

 
Back to Top